GlassScriptPhysician profile
Francisco A Quinteros
NPI 1427206689
$118,829.22
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $13K · 2022: $33K · 2023: $7,780 · 2024: $11K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $5,443 · Consulting Fee: $4,738 · Food and Beverage: $4,662 · Honoraria: $3,435 · Education: $79.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,975.00 |
| Travel and Lodging | $5,443.12 |
| Consulting Fee | $4,737.50 |
| Food and Beverage | $4,661.92 |
| Honoraria | $3,435.00 |
| Education | $79.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $42,129.42 | 2019-2025 | Gelport Laparoscopic System |
| Medtronic, INC. | $33,584.18 | 2021-2025 | Signia, Ligasure, Progrip |
| Covidien LP | $21,564.57 | 2019-2020 | |
| Thd America, INC. | $13,909.25 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $3,600.00 | 2022 | |
| Intuitive Surgical, INC. | $1,298.44 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $924.17 | 2023-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $664.75 | 2019-2025 | Seamguard Staple Line Reinforcement, Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $400.00 | 2021 | |
| Lsi Solutions INC | $125.00 | 2023 | Ti Knot, Fornisee, Running Device |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Tela Bio, INC. | $120.21 | 2024 | Ovitex 2s |
| Kerecis Limited | $102.29 | 2019 | |
| Innovation Technologies INC | $82.82 | 2025 | Irrisept |
| Conmed Corporation | $76.46 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $34.45 | 2022-2023 | Sutab, Suflave |
| Novo Nordisk INC | $27.77 | 2025 | Wegovy |
| Genentech USA, INC. | $25.80 | 2025 | Gazyva |
| Rigel Pharmaceuticals, INC. | $20.52 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.13 | 2023 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Quinteros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.